ORIGINAL RESEARCH article

Front. Immunol.

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1566061

This article is part of the Research TopicIntegrating Molecular Mechanisms, Immunotherapy, and Drug Sensitivity in Cancer Immunology and OncologyView all 24 articles

Glypican-3 regulated epithelial mesenchymal transformationrelated genes in osteosarcoma: based on comprehensive tumor microenvironment profiling

Provisionally accepted
  • 1Cancer Hospital of Dalian University of Technology, Liaoning cancer Hospital&Institute Department of Bone and Soft Tissue Tumor Surgery, Dalian, China
  • 2Department of Bone and Soft Tissue Tumor Surgery, Shenyang, China

The final, formatted version of the article will be published soon.

Osteosarcoma (OS) is the most common primary bone malignancy, and mainly affects children and adolescents. The current treatment approaches for OS have limited efficacy, and the 5-year survival rate is roughly 60%. Epithelial-mesenchymal transition (EMT) plays a key role in the onset, progression, and metastasis of OS, and may influence patient prognosis. In this study, we screened EMT-related genes from multiple transcriptomic datasets of OS, and performed unsupervised consensus clustering of EMT-related gene sets. The key genes related to EMT were identified by weighted gene co-expression network analysis (WGCNA), and intersected with the differentially expressed genes (DEGs) between OS and normal tissue samples. The least absolute shrinkage and selection operator (LASSO) algorithm was then used to screen candidate genes for developing a prognostic model. The predictive capacity of the EMT-based model was validated across several cohorts. Furthermore, the prognostic model also predicted immune-related features and immunotherapy responses in the high-risk and low-risk groups. We identified seven primary cell types from the scRNA-Seq data of OS samples, and found that the osteoblast population had the highest proportion of cells positive for the model genes. The OS_C3 subpopulation had significantly higher scores, and included nine gene modules associated with metabolism, structural integrity, proliferation, differentiation, adhesion, migration, immune responses, inflammatory reactions, and signal transduction. The model genes also showed prognostic value across various cancer types. Finally, the proliferation and migration ability were decrease after si-GPC3 in MG-63 cell line, In conclusion, this study provides new insights into the potential mechanisms of EMT in OS, and its impact on the tumor immune microenvironment and response to immunotherapy, which can pave the way for novel personalized treatment strategies.

Keywords: Osteosarcoma, Epithelial-to-mesenchymal, Prognostic model, Immune characteristics, gene expression analysis

Received: 24 Jan 2025; Accepted: 18 Apr 2025.

Copyright: © 2025 Zhang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Wei Wang, Department of Bone and Soft Tissue Tumor Surgery, Shenyang, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.